In AAA arbitration, CRA was retained by respondent regarding the interpretation of commercial terms in a licensing agreement related to medical devices. CRA considered the commercial rationale behind the development and commercialization aspects of the licensing agreement with respect to the characterization of new products that result from the research and development efforts of a licensee.
2024 International Arbitration review: Updates and trends
Dear Clients and Friends, Our activities in 2024 reflected ongoing trends from 2023 and emerging forces affecting the landscape for investors and companies...